Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kennedy’s Health Reform Briefing Paper: What It Could Mean

Executive Summary

Senate Health, Education, Labor & Pensions Committee Chairman Ted Kennedy, D-Mass., is placing his political capital behind a public health plan as part of any health care reform proposal

You may also be interested in...



Baucus Re-Introduces Comparative Effectiveness Bill, Adds “Safeguards” Between CER And Coverage Decisions

Finance Committee chairman would require opportunity for stakeholder comments, consideration of other research before CER results are used to revise HHS health coverage policy.

Health Reform Details Emerge: Get Ready for Medicare Part D Rebates, Follow-on Biologics

House Energy and Commerce health reform bill will likely include a minimum rebate for Medicare Part D dual-eligibles.

Supreme Court Pick Sotomayor Lacks Rx Track Record, But Vioxx Case Looms

Those poring over Judge Sonia Sotomayor's rulings can get a sense of her views on civil rights, environmental law, privacy and the Second Amendment right to bear arms. But there seems to be no indication of how President Obama's nominee to the Supreme Court might rule on issues affecting the pharmaceutical industry

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel